首页 | 本学科首页   官方微博 | 高级检索  
     


Successful treatment of hereditary angioedema with bradykinin B2‐receptor antagonist icatibant
Authors:Karoline Krause  Martin Metz  Torsten Zuberbier  Marcus Maurer  Markus Magerl
Affiliation:Allergie‐Centrum‐Charité, Department of Dermatology and Allergy, Charité‐Universit?tsmedizin Berlin,Germany
Abstract:The bradykinin B2 receptor antagonist icatibant has recently become available for treating hereditary angioedema. Our observations demonstrate icatibant to be effective and safe for the treatment of both, abdominal and cutaneous attacks in a practice setting beyond clinical studies.
Keywords:hereditary angioedema  Bradykinin  icatibant
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号